Cilostazol in Acute Ischemic Stroke Treatment (CAIST)

This study has been completed.

Study NCT00272454 Information provided by Korea Otsuka Pharmaceutical Co.,Ltd.

First Received: January 3, 2006 Last Updated: December 15, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study has been completed.
Study Completion Date:	September 2008
Estimated Primary Completion Date:	No date given

No publications provided by Korea Otsuka Pharmaceutical Co.,Ltd.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Lee YS, Bae HJ, Kang DW, Lee SH, Yu K, Park JM, Cho YJ, Hong KS, Kim DE, Kwon SU, Lee KB, Rha JH, Koo J, Han MG, Lee SJ, Lee JH, Jung SW, Lee BC, Kim JS. Cilostazol in Acute Ischemic Stroke Treatment (CAIST Trial): a randomized double-blind non-inferiority trial. Cerebrovasc Dis. 2011;32(1):65-71. Epub 2011 May 25.